Study | Year | Method of analysis | Nb of patients | FIGO stage | Macrometastatic SLN (%) | Micrometastatic SLN (%) |
---|---|---|---|---|---|---|
Burke | 1996 | H&E | 15 | I-II | 2 (13) | na |
Echt | 1999 | H&E | 8 | I-IV | na | na |
Holub | 2004 | H&E | 25 | I | 2 (8) | na |
Raspagliesi | 2004 | H&E | 18 | I-III | 4 (22) | na |
Altgassen | 2007 | H&E | 25 | I-II | 2 (8) | na |
Frumovitz | 2007 | H&E | 18 | I-II-III | 0 | na |
Li | 2007 | H&E | 20 | I-II-III | 2 (10) | na |
Pelosi | 2003 | H&E+IHC | 16 | I | 3 18) | 3 (18) |
Niikura | 2006 | H&E+IHC | 20 | I-II-III | 4 (20) | 4 (20) |